Edition:
United Kingdom

People: Achillion Pharmaceuticals Inc (ACHN.OQ)

ACHN.OQ on NASDAQ Stock Exchange Global Select Market

4.60USD
9:00pm BST
Change (% chg)

$-0.05 (-1.08%)
Prev Close
$4.65
Open
$4.63
Day's High
$4.67
Day's Low
$4.52
Volume
250,090
Avg. Vol
420,913
52-wk High
$5.02
52-wk Low
$1.29

Lantz, Keri 

Ms. Keri Lantz is Vice President - Finance, Corporate Controller of the Company. She has served as the Company’s Corporate Controller and Vice President of Finance since January 2017. From January 2014 to December 2016, Ms. Lantz served as the Company’s Corporate Controller and Executive Director, Financial Reporting and from January 2011 to December 2013 as the Company’s Corporate Controller and Senior Director, Financial Reporting. Prior to joining the Company in January 2007, Ms. Lantz, a certified public accountant, held positions at CUNO, Inc., a manufacturing and technology company which was acquired by 3M Company in 2005, and the accounting firm, Blum Shapiro. Ms. Lantz holds a Bachelor of Science in accounting from Central Connecticut State University.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --